ImmuneSupport.com reported last week that CFIDS is a “syndrome manifesting in cases with focal brain damage. It is also found in people who suffer from Multople Sclerosis and encephalopathies (post-traumatic, cerebrovascular, etc.).
Patients with CFIDS were given a drug called Fezam, which is refered to as a “smart drug”, 2 capsules, 3 times per day. Fezam contains a substance that “acts on the brain to boost functions or capabilities”.
The study revealed that Fesam caused patients with CFIDS to have less severity in their symptoms. In another group it was associated with a decrease of depression severity.
There were mild side-effects shown in 12% of the patients causing sleep disorders.